Personal information

Emails & domains

Verified email domains

Other IDs

Loop profile: 2528897

Activities

Collapse all

Employment (1)

Frederick National Laboratory for Cancer Research: Frederick, MD, US

2009-02-17 to present | Senior Research (Center for Advanced Preclinical Research)
Employment
Source: Self-asserted source
Rajaa El Meskini

Works (17)

Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer

EMBO Molecular Medicine
2024-02-16 | Journal article
DOI: 10.1038/s44321-024-00029-x
Contributors: Christopher W Schultz; Yang Zhang; Rajaa Elmeskini; Astrid Zimmermann; Haiqing Fu; Yasuhisa Murai; Darawalee Wangsa; Suresh Kumar; Nobuyuki Takahashi; Devon Atkinson et al.
Source: check_circle
Crossref

Data from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.c.7065726.v1
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

Data from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.c.7065726
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 1 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188618
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 1 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188618.v1
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 2 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188615
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 2 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188615.v1
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 3 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188612.v1
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 3 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188612
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 4 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188609.v1
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 4 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188609
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 5 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188606
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

FIGURE 5 from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188606.v1
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

Cancer Research Communications
2024-02-08 | Journal article
DOI: 10.1158/2767-9764.CRC-23-0321
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

Supplementary Table from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188603
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

Supplementary Table from Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer

2024-02-08 | Preprint
DOI: 10.1158/2767-9764.25188603.v1
Contributors: Nitin Roper; Rajaa El Meskini; Tapan Maity; Devon Atkinson; Amanda Day; Nathan Pate; Constance M. Cultraro; Svetlana Pack; Valerie Zgonc; Zoe Weaver Ohler et al.
Source: check_circle
Crossref

ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer

EMBO Molecular Medicine
2023-08-07 | Journal article
DOI: 10.15252/emmm.202217313
Contributors: Christopher W Schultz; Yang Zhang; Rajaa Elmeskini; Astrid Zimmermann; Haiqing Fu; Yasuhisa Murai; Darawalee Wangsa; Suresh Kumar; Nobuyuki Takahashi; Devon Atkinson et al.
Source: check_circle
Crossref
How many people are using ORCID?